32014R0605

EUR-Lex

Access to European Union law

This document is an excerpt from the EUR-Lex website

EUROPA
EUR-Lex home
Rialachán - 605/2014 - EN - EUR-Lex

Help

Search tips

Need more search options? Use the Advanced search

Document 32014R0605

Commission Regulation (EU) No 605/2014 of 5 June 2014 amending, for the purposes of introducing hazard and precautionary statements in the Croatian language and its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures Text with EEA relevance

IO L 167, 6.6.2014, p. 36–49 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

Legal status of the document In force

ELI: http://data.europa.eu/eli/reg/2014/605/oj

Date of document:: 05/06/2014
Date of effect:: 26/06/2014; Teacht i bhfeidhm Dáta foilsithe +20 Féach Airt. 3.1
Date of effect:: 01/12/2014; Cur i bhfeidhm Cur i bhfeidhm páirteach Féach Airt. 3.2
Date of effect:: 01/04/2015; Cur i bhfeidhm Cur i bhfeidhm páirteach Féach Airt. 3.3
Date of effect:: 01/06/2015; Cur i bhfeidhm Cur i bhfeidhm páirteach Féach Airt. 3.2
Date of end of validity:: No end date

Author:: An Coimisiún Eorpach
Form:: Rialachán
Additional information:: Ábharthacht maidir le LEE

Treaty:

An Conradh ar Fheidhmiú an Aontais Eorpaigh

Legal basis:

12012J050
32008R1272 - A37P5

Link

Select all documents mentioning this document

Modifies:

Relation	Act	Comment	Subdivision concerned	From
Modifies	32008R1272	Leasú	iarscríbhinn III
Modifies	32008R1272	Leasú	iarscríbhinn IV
Modifies	32008R1272	Leasú	iarscríbhinn VI	01/04/2015

Modified by:

Relation	Act	Comment	Subdivision concerned	From	To
Corrected by	32014R0605R(01)	(IT)
Modified by	32015R0491	Athchur	airteagal 3.3	25/03/2015

Instruments cited:

Link

EUROVOC descriptor:

Subject matter:

Margadh inmheánach

Directory code:

13.30.18.00 Beartas tionscalaíoch agus an margadh inmheánach / Margadh inmheánach: comhfhogasú reachtaíochta / Substaintí contúirteacha

HTML

PDF

Official Journal

6.6.2014

Official Journal of the European Union

L 167/36

COMMISSION REGULATION (EU) No 605/2014

of 5 June 2014

amending, for the purposes of introducing hazard and precautionary statements in the Croatian language and its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to the Act concerning the conditions of accession of the Republic of Croatia and the adjustments to the Treaty on European Union and the Treaty establishing the European Atomic Energy Community (1), and in particular Article 50 thereof,

Having regard to Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (2), and in particular Article 37(5) thereof,

Whereas:

(1)

Commission Regulation (EU) No 487/2013 (3) amends some of the language tables for hazard statements included in Annex III to Regulation (EC) No 1272/2008 and some of the language tables for precautionary statements included in Annex IV to that Regulation. With the accession of Croatia to the European Union on 1 July 2013, it is necessary that all hazard and precautionary statements provided for by Regulation (EC) No 1272/2008 as amended by Commission Regulation (EU) No 487/2013 are available in the Croatian language as well. This Regulation introduces the necessary adjustments to the language tables.

(2)

Part 3 of Annex VI to Regulation (EC) No 1272/2008 contains two lists of harmonised classification and labelling of hazardous substances. Table 3.1 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Parts 2 to 5 of Annex I to Regulation (EC) No 1272/2008. Table 3.2 lists the harmonised classification and labelling of hazardous substances based on the criteria set out in Annex VI to Council Directive 67/548/EEC (4).

(3)

Proposals for new or updated harmonised classification and labelling of certain substances have been submitted to the European Chemicals Agency (ECHA) pursuant to Article 37 of Regulation (EC) No 1272/2008. Based on the opinions on those proposals issued by the Committee for Risk Assessment of ECHA, as well as on the comments received from the parties concerned, it is appropriate to introduce, remove or update harmonised classification and labelling of certain substances by amending Annex VI to that Regulation.

(4)

Compliance with the new harmonised classifications should not be required immediately, as a certain period of time will be necessary to allow suppliers to adapt the labelling and packaging of substances and mixtures to the new classifications and to sell existing stocks. In addition, a certain period of time will be necessary to allow suppliers to comply with the registration obligations resulting from the new harmonised classifications for substances classified as carcinogenic, mutagenic or toxic to reproduction, categories 1A and 1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as very toxic to aquatic organisms which may cause long term effects in the aquatic environment, in particular with those set out in Article 23 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council (5).

(5)

In line with the transitional provisions of Regulation (EC) No 1272/2008 which allow the application of the new provisions at an earlier stage on a voluntary basis, suppliers should have the possibility of applying the new harmonised classifications and of adapting the labelling and packaging accordingly on a voluntary basis before the deadline for compliance.

(6)	The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article 133 of Regulation (EC) No 1907/2006,

HAS ADOPTED THIS REGULATION:

Article 1

Regulation (EC) No 1272/2008 is amended as follows:

(1)	Annex III is amended in accordance with Annex I to this Regulation;

(2)	Annex IV is amended in accordance with Annex II to this Regulation;

(3)	Annex VI is amended in accordance with Annex III to this Regulation.

Article 2

1. By way of derogation from Article 3(2), substances and mixtures may, before 1 December 2014 and 1 June 2015 respectively, be classified, labelled and packaged in accordance with this Regulation.

2. By way of derogation from Article 3(2), substances classified, labelled and packaged in accordance with Regulation (EC) No 1272/2008 and placed on the market before 1 December 2014, shall not be required to be relabelled and repackaged in accordance with this Regulation until 1 December 2016.

3. By way of derogation from Article 3(2), mixtures classified, labelled and packaged in accordance with Directive 1999/45/EC of the European Parliament and of the Council (6) or Regulation (EC) No 1272/2008 and placed on the market before 1 June 2015, shall not be required to be relabelled and repackaged in accordance with this Regulation until 1 June 2017.

4. By way of derogation from Article 3(3), the harmonised classifications set out in Annex III to this Regulation may be applied before the date referred to in Article 3(3).

Article 3

1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

2. Article 1(1) and (2) shall apply in respect of substances from 1 December 2014 and in respect of mixtures from 1 June 2015.

3. Article 1(3) shall apply from 1 April 2015.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 June 2014.

For the Commission

The President

José Manuel BARROSO

(1) OJ L 112, 24.4.2012, p. 21.

(2) OJ L 353, 31.12.2008, p. 1.

(3) Commission Regulation (EU) No 487/2013 of 8 May 2013 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and the Council on classification, labelling and packaging of substances and mixtures (OJ L 149, 1.6.2013, p. 1).

(4) Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (OJ L 196, 16.8.1967, p. 1).

(5) Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC (OJ L 396, 30.12.2006, p. 1).

(6) Directive 1999/45/EC of the European Parliament and of the Council of 31 May 1999 concerning the approximation of the laws, regulations and administrative provisions of the Member States relating to the classification, packaging and labelling of dangerous preparations (OJ L 200, 30.7.1999, p. 1).

ANNEX I

In Part 1 of Annex III, Table 1.1 is amended as follows:

(1)

in code H229, the following is inserted after the entry corresponding to GA:

‘HR

Spremnik pod tlakom: može se rasprsnuti ako se grije.’

(2)

in code H230, the following is inserted after the entry corresponding to GA:

‘HR

Može eksplozivno reagirati i bez prisustva zraka.’

(3)

in code H231, the following is inserted after the entry corresponding to GA:

‘HR

Može eksplozivno reagirati i bez prisustva zraka na povišenom tlaku i/ili temperaturi.’

ANNEX II

Part 2 to Annex IV is amended as follows:

(1)

Table 1.2 is amended as follows:

(a)

in code P210, the following is inserted after the entry corresponding to GA:

‘HR

Čuvati odvojeno od topline, vrućih površina, iskri, otvorenih plamena i ostalih izvora paljenja. Ne pušiti.’

(b)

in code P223: The following is inserted after the entry corresponding to GA:

‘HR

Spriječiti dodir s vodom.’

(c)

in code P244, the following is inserted after the entry corresponding to GA:

‘HR

Spriječiti dodir ventila i spojnica s uljem i masti.’

(d)

in code P251, the following is inserted after the entry corresponding to GA:

‘HR

Ne bušiti, niti paliti čak niti nakon uporabe.’

(e)

in code P284, the following is inserted after the entry corresponding to GA:

‘HR

[U slučaju nedovoljne ventilacije] nositi sredstva za zaštitu dišnog sustava.’

(2)

Table 1.3 is amended as follows:

(a)

in code P310, the following is inserted after the entry corresponding to GA:

‘HR

Odmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…’

(b)

in code P 311, the following is inserted after the entry corresponding to GA:

‘HR

Nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…’

(c)

in code P312: The following is inserted after the entry corresponding to GA:

‘HR

U slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…’

(d)

in code P340, the following is inserted after the entry corresponding to GA:

‘HR

Premjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.’

(e)

in code P352, the following is inserted after the entry corresponding to GA:

‘HR

Oprati velikom količinom vode/…’

(f)

in code P361, the following is inserted after the entry corresponding to GA:

‘HR

Odmah skinuti svu zagađenu odjeću.’

(g)

in code P362, the following is inserted after the entry corresponding to GA:

‘HR

Skinuti zagađenu odjeću.’

(h)

in code P364, the following is inserted after the entry corresponding to GA:

‘HR

I oprati je prije ponovne uporabe.’

(i)

in code P378, the following is inserted after the entry GA:

‘HR

Za gašenje rabiti …’

(j)

in combined codes P301 + P310, the following is inserted after the entry corresponding to GA:

‘HR

AKO SE PROGUTA: odmah nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…’

(k)

in combined codes P301 + P312, the following is inserted after the entry corresponding to GA:

‘HR

AKO SE PROGUTA: u slučaju zdravstvenih tegoba nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…’

(l)

in combined codes P302 + P352, the following is inserted after the entry corresponding to GA:

‘HR

U SLUČAJU DODIRA S KOŽOM: oprati velikom količinom vode/…’

(m)

in combined codes P303 + P361+P353, the following is inserted after the entry corresponding to GA:

‘HR

U SLUČAJU DODIRA S KOŽOM (ili kosom): odmah skinuti svu zagađenu odjeću. Isprati kožu vodom/tuširanjem.’

(n)

in combined codes P304 + P340, the following is inserted after the entry corresponding to GA:

‘HR

AKO SE UDIŠE: premjestiti osobu na svježi zrak i postaviti ju u položaj koji olakšava disanje.’

(o)

in combined codes P308 + P311, the following is inserted after the entry corresponding to GA:

‘HR

U SLUČAJU izloženosti ili sumnje na izloženost: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…’

(p)

in combined codes P342 + P311, the following is inserted after the entry corresponding to GA:

‘HR

Pri otežanom disanju: nazvati CENTAR ZA KONTROLU OTROVANJA/liječnika/…’

(q)

in combined codes P361 + P364, the following is inserted after the entry corresponding to GA:

‘HR

Odmah skinuti svu zagađenu odjeću i oprati je prije ponovne uporabe.’

(r)

in combined codes P362 + P364, the following is inserted after the entry corresponding to GA:

‘HR

Skinuti zagađenu odjeću i oprati je prije ponovne uporabe.’

(s)

in combined codes P370 + P378, the following is inserted after the entry corresponding to GA:

‘HR

U slučaju požara: za gašenje rabiti …’

ANNEX III

Part 3 of Annex VI is amended as follows:

(1)

Table 3.1 is amended as follows:

(a)	the entry corresponding to index number 015-188-00-X is deleted;

(b)

the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5, 605-008-00-3 and 616-035-00-5 are replaced by the following corresponding entries:

‘006-086-00-6	fenoxycarb (ISO); ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate	276-696-7	72490-01-8	Carc. 2 Aquatic Acute 1 Aquatic Chronic 1	H351 H400 H410	GHS08 GHS09 Wng	H351 H410		M = 1 M = 10 000
015-154-00-4	ethephon; 2-chloroethylphosphonic acid	240-718-3	16672-87-0	Acute Tox. 3 Acute Tox. 4 Acute Tox. 4 Skin Corr. 1C Aquatic Chronic 2	H311 H332 H302 H314 H411	GHS06 GHS05 GHS09 Dgr	H311 H332 H302 H314 H411	EUH071
015-192-00-1	tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate	432-770-2	139189-30-3	Skin Sens. 1	H317	GHS07 Wng	H317
601-023-00-4	ethylbenzene	202-849-4	100-41-4	Flam. Liq. 2 Acute Tox. 4* STOT RE 2 Asp. Tox. 1	H225 H332 H373 (hearing organs) H304	GHS02 GHS07 GHS08 Dgr	H225 H332 H373 (hearing organs) H304
601-026-00-0	styrene	202-851-5	100-42-5	Flam. Liq. 3 Repr. 2 Acute Tox. 4* STOT RE 1 Skin Irrit. 2 Eye Irrit. 2	H226 H361d H332 H372 (hearing organs) H315 H319	GHS02 GHS08 GHS07 Dgr	H226 H361d H332 H372 (hearing organs) H315 H319		*	D
603-061-00-7	tetrahydro-2-furylmethanol; tetrahydrofurfuryl alcohol	202-625-6	97-99-4	Repr. 1B Eye Irrit. 2	H360Df H319	GHS08 GHS07 Dgr	H360Df H319
605-001-00-5	formaldehyde …%	200-001-8	50-00-0	Carc. 1B Muta. 2 Acute Tox. 3* Acute Tox. 3* Acute Tox. 3* Skin Corr. 1B Skin Sens. 1	H350 H341 H301 H311 H331 H314 H317	GHS08 GHS06 GHS05 Dgr	H350 H341 H301 H311 H331 H314 H317		* Skin Corr. 1B; H314: C ≥ 25 % Skin Irrit. 2; H315: 5 % ≤ C < 25 % Eye Irrit. 2; H319: 5 % ≤ C < 25 % STOT SE 3; H335: C ≥ 5 % Skin Sens. 1; H317: C ≥ 0,2 %	B, D
605-008-00-3	acrolein; prop-2-enal; acrylaldehyde	203-453-4	107-02-8	Flam. Liq. 2 Acute Tox. 1 Acute Tox. 2 Acute Tox. 3 Skin Corr. 1B Aquatic Acute 1 Aquatic Chronic 1	H225 H330 H300 H311 H314 H400 H410	GHS02 GHS06 GHS05 GHS09 Dgr	H225 H330 H300 H311 H314 H410	EUH071	Skin Corr. 1B; H314: C ≥ 0,1 % M = 100 M = 1	D
616-035-00-5	cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide	261-043-0	57966-95-7	Repr. 2 Acute Tox. 4 STOT RE 2 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H361fd H302 H373 (blood, thymus) H317 H400 H410	GHS08 GHS07 GHS09 Wng	H361fd H302 H373 (blood, thymus) H317 H410		M = 1 M = 1’

(c)

the following entries are inserted in accordance with the order of the entries set out in Table 3.1:

‘050-028-00-2	2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate	260-829-0	57583-35-4	Repr. 2 Acute Tox. 4 STOT RE 1 Skin Sens. 1A	H361d H302 H372 (nervous system, immune system) H317	GHS08 GHS07 Dgr	H361d H302 H372 (nervous system, immune system) H317
050-029-00-8	dimethyltin dichloride	212-039-2	753-73-1	Repr. 2 Acute Tox. 2 Acute Tox. 3 Acute Tox. 3 STOT RE 1 Skin Corr. 1B	H361d H330 H301 H311 H372 (nervous system, immune system) H314	GHS08 GHS06 GHS05 Dgr	H361d H330 H301 H311 H372 (nervous system, immune system) H314	EUH071
601-088-00-9	4-vinylcyclohexene	202-848-9	100-40-3	Carc. 2	H351	GHS08 Wng	H351
601-089-00-4	muscalure; cis-tricos-9-ene	248-505-7	27519-02-4	Skin Sens. 1B	H317	GHS07 Wng	H317
604-090-00-8	4-tert-butylphenol	202-679-0	98-54-4	Repr. 2 Skin Irrit. 2 Eye Dam. 1	H361f H315 H318	GHS08 GHS05 Dgr	H361f H315 H318
604-091-00-3	etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether	407-980-2	80844-07-1	Lact. Aquatic Acute 1 Aquatic Chronic 1	H362 H400 H410	GHS09 Wng	H362 H410		M = 100 M = 1 000
606-146-00-7	tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one	-	87820-88-0	Carc. 2 Acute Tox. 4 Aquatic Chronic 2	H351 H302 H411	GHS08 GHS07 GHS09 Wng	H351 H302 H411
606-147-00-2	cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one	405-230-9	101205-02-1	Repr. 2	H361d	GHS08 Wng	H361d
607-705-00-8	benzoic acid	200-618-2	65-85-0	STOT RE 1 Skin Irrit. 2 Eye Dam. 1	H372 (lungs) (inhalation) H315 H318	GHS08 GHS05 Dgr	H372 (lungs) (inhalation) H315 H318
607-706-00-3	methyl 2,5-dichlorobenzoate	220-815-7	2905-69-3	Acute Tox. 4 STOT SE 3 Aquatic Chronic 2	H302 H336 H411	GHS07 GHS09 Wng	H302 H336 H411
612-287-00-5	fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine	-	79622-59-6	Repr. 2 Acute Tox. 4 Eye Dam. 1 Skin Sens. 1A Aquatic Acute 1 Aquatic Chronic 1	H361d H332 H318 H317 H400 H410	GHS08 GHS07 GHS05 GHS09 Dgr	H361d H332 H318 H317 H410		M = 10 M = 10
613-317-00-X	penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole	266-275-6	66246-88-6	Repr. 2 Acute Tox. 4 Aquatic Acute 1 Aquatic Chronic 1	H361d H302 H400 H410	GHS08 GHS07 GHS09 Wng	H361d H302 H410		M = 1 M = 1
613-318-00-5	fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate	-	473798-59-3	Aquatic Chronic 2	H411	GHS09	H411
616-212-00-7	3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate	259-627-5	55406-53-6	Acute Tox. 3 Acute Tox. 4 STOT RE 1 Eye Dam. 1 Skin Sens. 1 Aquatic Acute 1 Aquatic Chronic 1	H331 H302 H372 (larynx) H318 H317 H400 H410	GHS06 GHS08 GHS05 GHS09 Dgr	H331 H302 H372 (larynx) H318 H317 H410		M = 10 M = 1’

(2)

Table 3.2 is amended as follows:

(a)	the entry corresponding to index number 015-188-00-X is deleted;

(b)

the entries corresponding to index numbers 006-086-00-6, 015-154-00-4, 015-192-00-1, 601-023-00-4, 601-026-00-0, 603-061-00-7, 605-001-00-5 and 616-035-00-5 are replaced by the following corresponding entries:

‘006-086-00-6	fenoxycarb (ISO);ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate	276-696-7	72490-01-8	Carc. Cat. 3; R40 N; R50-53	Xn; N R: 40-50/53 S: (2-)22-36/37-60-61	N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 %
015-154-00-4	ethephon; 2-chloroethylphosphonic acid	240-718-3	16672-87-0	C; R34 Xn; R20/21/22 N; R51-53	C; N R: 20/21/22-34-51/53 S: (1/2-)26-36/37/39-45-61	Xi; R37: 5 % ≤ C < 10 %
015-192-00-1	tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate	432-770-2	139189-30-3	R43	Xi R: 43 S: (2-)24-37
601-023-00-4	ethylbenzene	202-849-4	100-41-4	F; R11 Xn; R20-48/20-65	F; Xn R: 11-20-48/20-65 S: (2-)16-24/25-29-62
601-026-00-0	styrene	202-851-5	100-42-5	Repr. Cat. 3; R63 Xn; R20-48/20 Xi; R36/38 R10	Xn R: 10-20-36/38-48/20-63 S: (2-)23-36/37-46	Xn; R20: C ≥ 12,5 % Xi; R36/38: C ≥ 12,5 %	D
603-061-00-7	tetrahydro-2-furylmethanol; tetrahydrofurfuryl alcohol	202-625-6	97-99-4	Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xi; R36	T R: 36-61-62 S: 45-53	Xi; R36: C ≥ 10 %
605-001-00-5	formaldehyde …%	200-001-8	50-00-0	Carc. Cat. 2; R45 Muta. Cat. 3; R68 T; R23/24/25 C; R34 R43	T R: 23/24/25-34-43-45-68 S: 45-53	T; R23/24/25: C ≥ 25 % Xn; R20/21/22: 5 % ≤ C < 25 % C; R34: C ≥ 25 % Xi; R36/37/38: 5 % ≤ C < 25 % R43: C ≥ 0,2 %	B, D
616-035-00-5	cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide	261-043-0	57966-95-7	Repr. Cat. 3; R62-63 Xn; R22-48/22 R43 N; R50-53	Xn; N R: 22-43-48/22-62-63-50/53 S: (2-)36/37-46-60-61	N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 %’

(c)

the following entries are inserted in accordance with the order of the entries set out in Table 3.2:

‘050-028-00-2	2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate	260-829-0	57583-35-4	Repr. Cat. 3; R63 T; R48/25 Xn; R22 R43	T R: 22-43-48/25-63 S: (1/2-)36/37-45
050-029-00-8	dimethyltin dichloride	212-039-2	753-73-1	Repr. Cat. 3; R63 T+; R26 T; R24/25-48/25 C; R34	T+ R: 24/25-26-34-48/25-63 S: (1/2-)26-28-36/37/39-45-63
601-088-00-9	4-vinylcyclohexene	202-848-9	100-40-3	Carc. Cat. 3; R40	Xn R: 40 S: (2-)36/37
601-089-00-4	muscalure; cis-tricos-9-ene	248-505-7	27519-02-4	R43	Xi R: 43 S: (2-)24-37
604-090-00-8	4-tert-butylphenol	202-679-0	98-54-4	Repr. Cat. 3; R62 Xi; R38-41	Xn R: 38-41-62 S: (2-)26-36/37/39-46
604-091-00-3	etofenprox (ISO); 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzyl ether	407-980-2	80844-07-1	R64 N; R50-53	N R: 50/53-64 S: 60-61	N; R50-53: C ≥ 0,25 % N; R51-53: 0,025 % ≤ C < 0,25 % R52-53: 0,0025 % ≤ C < 0,025 %
606-146-00-7	tralkoxydim (ISO); 2-(N-ethoxypropanimidoyl)-3-hydroxy-5-mesitylcyclohex-2-en-1-one	–	87820-88-0	Carc. Cat. 3; R40 Xn; R22 N; R51-53	Xn; N R: 22-40-51/53 S: (2-)36/37-60-61
606-147-00-2	cycloxydim (ISO); 2-(N-ethoxybutanimidoyl)-3-hydroxy-5-(tetrahydro-2H-thiopyran-3-yl)cyclohex-2-en-1-one	405-230-9	101205-02-1	F; R11 Repr. Cat. 3; R63	F; Xn R: 11-63 S: (2-)16-36/37-46
607-705-00-8	benzoic acid	200-618-2	65-85-0	T; R48/23 Xi; R38-41	T R: 38-41-48/23 S: (1/2-)26-39-45-63
607-706-00-3	methyl 2,5-dichlorobenzoate	220-815-7	2905-69-3	Xn; R22 N; R51-53	Xn; N R: 22-51/53 S: (2-) 46-61
612-287-00-5	fluazinam (ISO); 3-chloro-N-[3-chloro-2,6-dinitro-4-(trifluoromethyl)phenyl]-5-(trifluoromethyl)pyridin-2-amine	-	79622-59-6	Repr. Cat. 3; R63 Xn; R20 Xi; R41 R43 N; R50-53	Xn; N R: 20-41-43-50/53-63 S: (2-)26-36/37/39-46-60-61	N; R50-53: C ≥ 2,5 % N; R51-53: 0,25 % ≤ C < 2,5 % R52-53: 0,025 % ≤ C < 0,25 %
613-317-00-X	penconazole (ISO); 1-[2-(2,4-dichlorophenyl)pentyl]-1H-1,2,4-triazole	266-275-6	66246-88-6	Repr. Cat. 3; R63 Xn; R22 N; R50-53	Xn; N R: 22-50/53-63 S: (2-) 36/37-46-60-61	N; R50-53: C ≥ 25 % N; R51-53: 2,5 % ≤ C < 25 % R52-53: 0,25 % ≤ C < 2,5 %
613-318-00-5	fenpyrazamine (ISO); S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydro-1H-pyrazole-1-carbothioate	-	473798-59-3	N; R51-53	N R: 51/53 S: 60-61
616-212-00-7	3-iodo-2-propynyl butylcarbamate; 3-iodoprop-2-yn-1-yl butylcarbamate	259-627-5	55406-53-6	T; R23-48/23 Xn; R22 Xi; R41 R43 N; R50	T; N R: 22-23-41-43-48/23-50 S: (1/2-)24-26-37/39-45-63	N; R50: C ≥ 2,5 %’

Top

All

Choose the experimental features you want to try